Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 7 (6) , 333-344
- https://doi.org/10.1016/j.drup.2004.11.001
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Resveratrol modulates the phosphoinositide 3‐kinase pathway through an estrogen receptor α‐dependent mechanism: Relevance in cell proliferationInternational Journal of Cancer, 2003
- A Permissive Apoptotic Environment: Function of a Decrease in Intracellular Superoxide Anion and Cytosolic AcidificationBiochemical and Biophysical Research Communications, 2002
- Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapseInternational Journal of Cancer, 2001
- The Role of Cyclooxygenase and Lipoxygenase in Cancer ChemopreventionDrug Metabolism and Drug Interactions, 2000
- Is Resveratrol an Estrogen Agonist in Growing Rats?Endocrinology, 1999
- Resveratrol Arrests the Cell Division Cycle at S/G2 Phase TransitionBiochemical and Biophysical Research Communications, 1998
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Effects of stilbenes on arachidonate metabolism in leukocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injuryPhysiological Plant Pathology, 1976